![]() |
市場調查報告書
商品編碼
1715166
2031年北美間歇導管市場預測-區域分析-依產品、適應症、類別、系統類型及最終用戶North America Intermittent Catheters Market Forecast to 2031 - Regional Analysis - by Product, Indication, Category, System Type, and End User |
2023年北美間歇導管市值為10.3579億美元,預計到2031年將達到15.0664億美元;預計2023年至2031年的複合年成長率為4.8%。
尿失禁盛行率飆升推動北美間歇導尿管市場發展
尿失禁(UI)是影響全球大量人口最常見的問題。在更嚴重的情況下,它會導致偶爾或輕微的漏尿或無法控制的慢性排尿。肥胖症的盛行率日益增加;老年人口不斷增加;前列腺癌、糖尿病、腎臟疾病和多發性硬化症等慢性疾病的發生率上升是 UI 的主要危險因子。脊髓損傷、腦性麻痺、攝護腺增大、多發性硬化症和癌症等疾病可能會導致老年族群出現 UI。
隨著全球老齡人口的激增,失業保險對醫療保健系統的經濟負擔也隨之增加。根據世界衛生組織(WHO)的數據,2020年全球60歲以上人口總數為10億,預計2031年將達到14億人。根據梅奧診所健康系統2023年發表的一篇文章,尿液不受控制地漏出是一種常見症狀,影響著幾乎50%的老年人口。這種疾病的盛行率隨著年齡的成長而增加,且任何年齡層的女性盛行率都高於男性; 65歲以上的女性中,高達75%的人患有漏尿。每天數次將間歇性導尿管通過尿道插入患者的膀胱,將尿液排出體外;它會在膀胱中保留足夠長的時間以排出膀胱中的液體,然後再將其取出。透過導尿,人們可以更好地控制膀胱。一旦膀胱排空並移除導尿管,人們就可以繼續他們的日常活動,而不會受到任何阻礙和尷尬。因此,UI 的盛行率不斷上升正在推動間歇導管市場的成長。
北美間歇導管市場概覽
根據人口參考局的數據,2023 年 65 歲及以上人口數為 5,800 萬,預計到 2050 年將增加到 8,200 萬。這一老化人口更容易受到脊髓損傷 (SCI)、尿失禁和良性前列腺增生的影響。例如,根據疾病管制與預防中心的數據,尿失禁是 65 歲或以上族群的主要症狀,原因多種多樣,包括糖尿病和中風等慢性疾病、認知障礙和發病率障礙。此外,根據美國國家脊髓損傷統計中心的估計,美國每年有 17,500 人患有脊髓損傷,尤其是老年族群。脊髓損傷患者主要需要導尿來控制神經性膀胱功能障礙,其中主要使用導尿管。因此,預計導尿管使用量的不斷成長將推動該國導尿管市場的成長。
北美間歇導管市場收入及預測(2031 年)(百萬美元)
北美間歇導管市場細分
北美間歇導管市場分為產品、適應症、類別、系統類型、最終用戶和國家。
根據產品,北美間歇導管市場分為塗層間歇導管和無塗層間歇導管。 2023 年,塗層間歇導管部分佔據了北美間歇導管市場的較大佔有率。
就適應症而言,北美間歇性導管市場分為尿失禁、普通手術、脊髓損傷、帕金森氏症 (pd)、多發性硬化症等。 2023 年,尿失禁領域佔據北美間歇導管市場的最大佔有率。
根據類別,北美間歇導管市場包括女性長度導管、男性長度導管和兒童長度導管。 2023 年,女性長度導管佔據北美間歇導管市場的最大佔有率。
根據系統類型,北美間歇導管市場分為封閉式間歇導管系統和開放式間歇導管系統。 2023 年,封閉式間歇導管系統部分佔據了北美間歇導管市場的較大佔有率。
就最終用戶而言,北美間歇導管市場分為醫院、門診手術中心、家庭護理機構和其他。 2023 年,醫院部門佔據北美間歇導管市場的最大佔有率。
根據國家/地區,北美間歇導管市場分為美國、加拿大和墨西哥。 2023 年,美國佔據北美間歇導管市場的最大佔有率。
Advin Health Care Pvt Ltd; B 布勞恩 SE;波士頓科學公司;康德樂健康公司;康樂保公司;康維泰克集團股份有限公司;霍利斯特公司;佐治亞醫療技術公司; Teleflex 公司;和 Wellspect HealthCare 是北美間歇性導管市場的一些領先公司。
The North America intermittent catheters market was valued at US$ 1,035.79 million in 2023 and is expected to reach US$ 1,506.64 million by 2031; it is estimated to register a CAGR of 4.8% from 2023 to 2031.
Surging Prevalence of Urinary Incontinence Fuels North America Intermittent Catheters Market
Urinary incontinence (UI) is the most common problem affecting a substantial global population. It results in occasional or minor leaking or uncontrolled chronic urination, in worse cases. The growing prevalence of obesity; the increasing geriatric population; and the rising incidence of chronic diseases such as prostate cancer, diabetes, kidney diseases, and multiple sclerosis are among the prime risk factors for UI. Medical conditions such as spinal cord injuries, cerebral palsy, prostate enlargement, multiple sclerosis, and cancer, among others, may lead to UI in the geriatric population.
The economic burden of UI on healthcare systems grows with the surging elderly population across the world. According to the World Health Organization (WHO), the total population aged 60 and above was 1 billion in 2020, and it is expected to reach 1.4 billion by 2031. According to an article published by Mayo Clinic Health System in 2023, the uncontrolled leakage of urine is a common symptom that affects almost 50% of the elderly population. The prevalence of this condition increases with age, and it affects more women than men of any age; up to 75% of women over 65 suffer from urine leakage. Intermittent urinary catheters are inserted into the bladder of individuals through the urethra several times a day to carry urine out of their body; it is kept in the bladder for just long enough to drain it before removing it. By catheterizing themselves, people can gain better control over their bladder. Once the catheter is removed after the bladder is emptied, people can continue their daily activities without any hindrances and awkwardness. Thus, the rising prevalence of UI is driving the growth of the intermittent catheters market.
North America Intermittent Catheters Market Overview
According to the Population Reference Bureau, the number of people aged 65 and above was 58 million in 2023 and it is estimated to increase to 82 million by 2050. This aging population is more susceptible to spinal cord injury (SCI), urinary incontinence, and benign prostate hyperplasia. For instance, according to the Centers for Disease Control and Prevention, urinary incontinence is a major symptom among people aged 65 or above due to various factors, including chronic conditions such as diabetes and stroke, cognitive impairment, and morbidity impairment. Moreover, according to the National Spinal Cord Injury Statistical Center, it was estimated that each year, 17,500 people were suffering from SCI in the US, especially among the geriatric population. Patients affected by SCI majorly need the help of urinary catheterization to control neurogenic bladder dysfunction, where urinary catheters are mainly used. Thus, the growing use of urinary catheters is expected to fuel the growth of the urinary catheters market in the country.
North America Intermittent Catheters Market Revenue and Forecast to 2031 (US$ Million)
North America Intermittent Catheters Market Segmentation
The North America intermittent catheters market is categorized into product, indication, category, system type, end user, and country.
By product, the North America intermittent catheters market is segmented into coated intermittent catheters and uncoated intermittent catheters. The coated intermittent catheters segment held a larger share of the North America intermittent catheters market share in 2023.
In terms of indication, the North America intermittent catheters market is segmented into urinary incontinence, general surgeries, spinal cord injuries, Parkinson's Disease (pd), multiple sclerosis, and others. The urinary incontinence segment held the largest share of the North America intermittent catheters market share in 2023.
Based on category, the North America intermittent catheters market is female length catheters, male length catheters, and kid length catheters. The female length catheters segment held the largest share of the North America intermittent catheters market share in 2023.
By system type, the North America intermittent catheters market is bifurcated into closed intermittent catheters systems and open intermittent catheters systems. The closed intermittent catheters systems segment held a larger share of the North America intermittent catheters market share in 2023.
In terms of end user, the North America intermittent catheters market is segmented into hospitals, ambulatory surgical centers, home care settings, and others. The hospitals segment held the largest share of the North America intermittent catheters market share in 2023.
Based on country, the North America intermittent catheters market is segmented into the US, Canada, and Mexico. The US segment held the largest share of North America intermittent catheters market in 2023.
Advin Health Care Pvt Ltd; B Braun SE; Boston Scientific Corp; Cardinal Health Inc; Coloplast Corp; Convatec Group Plc; Hollister Inc; Medical Technologies of Georgia, Inc.; Teleflex Inc; and Wellspect HealthCare are some of the leading companies operating in the North America intermittent catheters market.